Skip to main content

Weather alert

Due to winter storm Fern, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Evaluating Whole-Genome Sequencing as a Viable Replacement for Chromosomal Microarray Using the DRAGEN v4.4 Cytogenetics Module

ASHG 2025

American Society of Human Genetics

Boston, MA, Oct 14-18, 2025

Poster presentation: Evaluating Whole-Genome Sequencing as a Viable Replacement for Chromosomal Microarray Using the DRAGEN v4.4 Cytogenetics Module

Pg. 3191

Authors: Gao Y, Brundu F, Lee Y, Ma J, South S, Bui P, Fleharty M, Larkin K, Popic V, Truong S, Hofherr S, Lennon N

Medical Specialty: Genetics

Related content

Audio Podcast
The power of laboratory analytics
Audio Podcast
Achieving the Triple Aim through the power of strong laboratory partnerships
Publication
Learning the Cellular Origins Across Cancers Using Single-Cell Chromatin Landscapes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.